AFFiRiS AG: Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing
Thursday, November 19, 2009 - 05:56
in Health & Medicine
Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing